-- Days : -- HRS : -- MIN : -- SEC

Register Now →

Subscribe

News
Video
Podcasts
Journals
Conferences
Events
Resources
CE
About AJMC
Subscribe

Spotlight -

Free In-Person Regional Events Focused on Oncology and Population Health

Kimberly Laubmeier, PhD

Articles by Kimberly Laubmeier, PhD

Formulary Restrictions on Atypical Antipsychotics: Impact on Costs for Patients With Schizophrenia and Bipolar Disorder in Medicaid

BySeth A. Seabury, PhD,Dana P. Goldman, PhD,Iftekhar Kalsekar, PhD,John J Sheehan, PhD,Kimberly Laubmeier, PhD,Darius N. Lakdawalla, PhD

February 24th 2014

Retrospective analysis of medical and pharmacy claims for patients diagnosed with schizophrenia or bipolar disorder in 24 state Medicaid programs.

Latest Updated Articles

Formulary Restrictions on Atypical Antipsychotics: Impact on Costs for Patients With Schizophrenia and Bipolar Disorder in Medicaid
February 24th 2014

Trending on AJMC

Patient Portal Messages Outpace Office Visits

Legend Biotech’s CAR T-cell Therapy Shows Early Promise in SCLC, Other Tumors

Flatiron’s AI-Driven Telescope Makes Data Access More User-Friendly

A Case for SGLT2 Inhibitors in Non-Diabetic CKD: Sandra Chaparro, MD

FDA Issues Complete Response Letter for Cytisinicline NDA, Citing Manufacturing Deficiencies